Weight-Loss drug tested as potential Game-Changer for alcohol addiction in veterans
NCT ID NCT07218354
Summary
This study is testing if semaglutide, a medication currently used for weight loss and diabetes, can help veterans with moderate to severe alcohol use disorder. About 440 participants will receive either weekly injections of semaglutide or a placebo for 28 weeks to see if it reduces heavy drinking days and lowers their overall risk level. The goal is to find a new, more effective treatment option for a condition that affects many veterans but has seen few new medications in nearly 20 years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104-4551, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.